110 likes | 241 Views
40th Annual Meeting Clinical Track Program “Cradle to the Grave” Issues in the Pediatric and Master’s Athlete February 10-11, 2012 Jacksonville, Fl. 2012 Clinical Track Supporters. Disclosure Statement.
E N D
40th Annual Meeting Clinical Track Program “Cradle to the Grave” Issues in the Pediatric and Master’s Athlete February 10-11, 2012 Jacksonville, Fl
Disclosure Statement The Hawkins FoundationGreenville Hospital SystemDJO SurgicalTornier CannonBreg ArthrocareEuflexxa OttoBachSmith & Nephew
Disclosure Statement Jason Folk, MD Consultant for Smith&Nephew Endoscopy
Disclosure Statement: Product / Unlabeled Use DiscussionDr. Steven Sabo Product:adalimumab (Humira) Unlabeled use:Pigmented Villonodular Synovitis refractory to Surgery Product:Tumor Necrosis Factor alpha inhibitors (class drugs) examples below as reported in peer reviewed Rheumatology literature case studies Unlabeled use:Pigmented Villonodular Synovitis refractory to Surgery Product:etanercept (Enbrel) and infliximab (Remicade) Unlabeled use:Pigmented Villonodular Synovitis refractory to Surgery
Disclosure Statement All other speakers/planners have no financial relationships to disclose
Kyle Cassas, MD, FACSM (Chair) Franklin Sease, MD (Vice Chair) Chad Asplund, MD Kenneth Barnes, MD Sean Bryan, MD Dave Sealy, MD Heather Fullerton, MD Rob Hosey, MD Charles Lascano, MD Clinical Track Planning Committee
Please thank our exhibitors and clinical track supporters who make this meeting possible! Please put your mobile devices on vibrate or silent mode.
We need your email address to mail out certificates after the meeting. • CEU’s may also be available this year.
Thanks to Cecilia Hanna and the Hawkins Foundation for providing CME.
Clinical Reception will be held in River Terrace 2 Friday-6:30-8:00pm Presented by the Steadman Hawkins Clinic of the Carolinas